scholarly article | Q13442814 |
P2093 | author name string | Howard A Reber | |
Oscar J Hines | |||
Clifford Y Ko | |||
David J Bentrem | |||
James J Farrell | |||
James S Tomlinson | |||
Nabil Wasif | |||
P2860 | cites work | Intraductal papillary mucinous neoplasms of the pancreas: an updated experience | Q24540094 |
Frozen sectioning of the pancreatic cut surface during resection of intraductal papillary mucinous neoplasms of the pancreas is useful and reliable: a prospective evaluation | Q33991839 | ||
Impact of tumor grade on prognosis in pancreatic cancer: should we include grade in AJCC staging? | Q34075815 | ||
Intraductal papillary mucinous neoplasms: predictors of malignant and invasive pathology | Q34583263 | ||
Prognosis of malignant intraductal papillary mucinous tumours of the pancreas after surgical resection. Comparison with pancreatic ductal adenocarcinoma. | Q35595090 | ||
Intraductal papillary mucinous neoplasms of the pancreas: an analysis of clinicopathologic features and outcome. | Q35742485 | ||
Genetic progression and heterogeneity in intraductal papillary-mucinous neoplasms of the pancreas. | Q35764095 | ||
Genetic alterations in the adenoma--carcinoma sequence | Q35782149 | ||
International consensus guidelines for management of intraductal papillary mucinous neoplasms and mucinous cystic neoplasms of the pancreas | Q36331064 | ||
Experience with 208 resections for intraductal papillary mucinous neoplasm of the pancreas | Q37223256 | ||
Outcome of invasive and noninvasive intraductal papillary-mucinous neoplasms of the pancreas (IPMN): a 10-year experience | Q37230982 | ||
Pathology of cancer of the pancreas. | Q41690575 | ||
Mucus is a predictor of better prognosis and survival in patients with intraductal papillary mucinous tumor of the pancreas | Q44297350 | ||
Outcomes following resection of invasive and noninvasive intraductal papillary mucinous neoplasms of the pancreas | Q44910275 | ||
Extent of lymph node retrieval and pancreatic cancer survival: information from a large US population database | Q46988284 | ||
Main-duct intraductal papillary mucinous neoplasms of the pancreas: clinical predictors of malignancy and long-term survival following resection | Q50149608 | ||
Intraductal papillary mucinous neoplasms of the pancreas: an increasingly recognized clinicopathologic entity | Q74428893 | ||
Study of recurrence after surgical resection of intraductal papillary mucinous neoplasm of the pancreas | Q78439518 | ||
Incidence of additional primary cancers in patients with invasive intraductal papillary mucinous neoplasms and sporadic pancreatic adenocarcinomas | Q80269666 | ||
Survival and prognosis of invasive intraductal papillary mucinous neoplasms of the pancreas: comparison with pancreatic ductal adenocarcinoma | Q80487536 | ||
Surgical outcome of intraductal papillary mucinous neoplasms of the pancreas | Q80786626 | ||
Outcomes after pancreatectomy for intraductal papillary mucinous neoplasms of the pancreas: an institutional experience | Q81470145 | ||
Preoperative evaluation of invasive and noninvasive intraductal papillary-mucinous neoplasms of the pancreas: clinical, radiological, and pathological analysis of 123 cases | Q81715427 | ||
Invasive carcinoma originating in an intraductal papillary mucinous neoplasm of the pancreas: a clinicopathologic comparison with a common type of invasive ductal carcinoma | Q83181935 | ||
Intraductal papillary mucinous neoplasms of the pancreas | Q95824673 | ||
P433 | issue | 14 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | mucinous tumor | Q6931145 |
adenocarcinoma | Q356033 | ||
Intraductal papillary mucinous neoplasm | Q17149811 | ||
pancreatic adenocarcinoma | Q18556189 | ||
P304 | page(s) | 3369-3377 | |
P577 | publication date | 2010-07-01 | |
P1433 | published in | Cancer | Q326041 |
P1476 | title | Invasive intraductal papillary mucinous neoplasm versus sporadic pancreatic adenocarcinoma: a stage-matched comparison of outcomes | |
P478 | volume | 116 |
Q35948154 | A 71-year-old man with a large cystic pancreatic mass. |
Q35101113 | A mutated anti-CA19-9 scFv-Fc for positron emission tomography of human pancreatic cancer xenografts |
Q92458173 | AJCC 7th edition staging classification is more applicable than AJCC 8th edition staging classification for invasive IPMN |
Q55292571 | Comparison of guidelines for intraductal papillary mucinous neoplasm: What is the next step beyond the current guidelines? |
Q40063273 | Comparison of the diagnostic accuracy of three current guidelines for the evaluation of asymptomatic pancreatic cystic neoplasms |
Q36699293 | Decision making for pancreatic resection in patients with intraductal papillary mucinous neoplasms |
Q54255971 | Endoscopically acquired pancreatic cyst fluid microRNA 21 and 221 are associated with invasive cancer. |
Q54943890 | European evidence-based guidelines on pancreatic cystic neoplasms. |
Q36985263 | Expansion of epigenetic alterations in EFEMP1 promoter predicts malignant formation in pancreatobiliary intraductal papillary mucinous neoplasms |
Q38147548 | Improvement of surgical results for pancreatic cancer |
Q28087395 | Intraductal Papillary Mucinous Neoplasm of the Pancreas: Current Perspectives |
Q36747321 | Intraductal papillary mucinous neoplasm (IPMN) with high-grade dysplasia is a risk factor for the subsequent development of pancreatic ductal adenocarcinoma |
Q34657866 | Intraductal papillary mucinous neoplasm of the pancreas: an update |
Q57494381 | Intraductal papillary mucinous neoplasm to pancreas ductal adenocarcinoma sequence and pancreas cancer screening |
Q37990820 | Intraductal papillary mucinous neoplasms of the pancreas--a surgical disease |
Q26796497 | Main- and Branch-Duct Intraductal Papillary Mucinous Neoplasms: Extent of Surgical Resection |
Q89848555 | Nomograms predicting long-term survival in patients with invasive intraductal papillary mucinous neoplasms of the pancreas: A population-based study |
Q36281575 | Pancreatic Cancer: Current Options for Diagnosis, Staging and Therapeutic Management |
Q34036659 | Pancreatic cancer-improved care achievable |
Q38354856 | Pancreatic cancer: diagnosis and treatments |
Q26783953 | Prevalence, Diagnosis and Management of Pancreatic Cystic Neoplasms: Current Status and Future Directions |
Q38200922 | Systematic review and meta-analysis comparing the surgical outcomes of invasive intraductal papillary mucinous neoplasms and conventional pancreatic ductal adenocarcinoma. |
Q39157286 | The Clinical Indications for Limited Surgery of Intraductal Papillary Mucinous Neoplasms of the Pancreas |
Q40297931 | The efficacy of adjuvant therapy for pancreatic invasive intraductal papillary mucinous neoplasm (IPMN). |
Q34471577 | The good, the bad and the ugly: a tale of miR-101, miR-21 and miR-155 in pancreatic intraductal papillary mucinous neoplasms |
Q36275909 | Tumor-associated Neutrophils and Malignant Progression in Intraductal Papillary Mucinous Neoplasms: An Opportunity for Identification of High-risk Disease |
Q50504926 | [Branch duct intraductal papillary mucinous neoplasm - surgical approach]. |
Search more.